Zika is a mosquito borne virus that can be dangerous in pregnant women as it can cause severe congenital malformations and damage to the baby. The extent of danger however is not known and a large study followed children who were exposed to this virus during their time within the womb.

Young children are far more vulnerable to climate-related disasters and the onus is on adults to provide the protection and care that children need, according to research by Columbia University's Mailman School of Public Health and Columbia University Irving Medical Center.

Dengue and Zika viruses are closely related and carried by mosquitos. In infested subtropical and tropical areas, dengue transmission often precedes Zika virus infection, suggesting that women who previously acquired dengue immunity may be bitten by ZIKV-carrying mosquitoes during pregnancy.

Zika virus may be sexually transmissible for a shorter period than previously estimated, according to a systematic review published this week in PLOS Medicine by Michel Counotte and Nicola Low of the University of Bern in Switzerland, and colleagues from the World Health Organization, US Centers for Disease Control and National Institute of Allergy and Infectious Disease. The review included analysis of data from both human and animal studies, and was conducted to describe the epidemiology of sexual transmission of ZIKV.

Until recently, the Zika virus was not a priority since it affected relatively few people and the cost of creating a vaccine was estimated at EUR 149-468 million. But the spread of Zika in the Americas and discovery of a link with reduced head size and brain damage in babies of women infected while pregnant changed that.

Entomologists at the University of California, Riverside have received a five-year grant of $2.44 million from the National Institute of Allergy and Infectious Diseases, or NIAID, to investigate the role hormones play in the female mosquito's ability to use human blood for egg production.

A startup created by Purdue University professors is developing a sensor that can detect dangerous mosquito-borne tropical diseases faster and at a lower cost than current methods, giving health officials time to take action before the viruses are transmitted to humans.

A new and promising class of chemical compounds has major potential for treating Zika virus and respiratory syncytial virus, or RSV, according to a new study by University of Alberta scientists. The next step is to develop a drug.

A collaborative study between six of the National Primate Research Centers shows pregnancy loss due to Zika A infections that don't cause women any symptoms may be a common but unrecognized cause of miscarriages and stillbirths.

In a summer outbreak that posed significant risks to pregnant women and their fetuses, 29 people in Miami-Dade County were infected with the Zika virus between late June and early August of 2016, according to the Centers for Disease Control and Prevention.

Oxitec, a company based in the UK, have developed what they call “Friendly mosquitoes”. These are bio-engineered male mosquitoes that would mate with the female to result in baby mosquitoes that die before they reach adulthood. This death before adulthood would be only for the female offspring.

Another deadly virus called the Keystone virus that could cause serious brain infection and is transmitted by mosquito bites has been found for the first time to be infecting humans. Until now the virus was noted to infect only animals.

Rhesus macaque monkeys infected in utero with Zika virus develop similar brain pathology to human infants, according to a report by researchers at the California National Primate Research Center and School of Veterinary Medicine at the University of California, Davis, published June 20 in Nature Communications.

Following the Zika virus epidemic that swept across Brazil between 2015-2016, Dr. Julia Clarke and her team begun working to establish the long-term effects of Zika, and recently discovered that TNF-a inhibitors can be used to prevent microencephaly.

In this interview, Haiying Zhang, Assistant Professor of Cell and Development Biology from the Department of Pediatrics at Weill Cornell Medicine talks to News – Medical about the importance of Exosomes.

At St. John's, we are building an innovation center in pharmaceutical technology. We are involved with double upping new drug delivery systems, as well as a new processing agreement. In addition, we are focussing on personalized medications.

Other Useful Links

News-Medical.Net provides this medical information service in accordance
with these terms and conditions.
Please note that medical information found
on this website is designed to support, not to replace the relationship
between patient and physician/doctor and the medical advice they may provide.

By continuing to browse or by clicking "Accept All Cookies," you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Find out more.